These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15095606)

  • 1. [Schizophrenia today: clinical and therapeutic approach; new relational data].
    Quartier F; Beyeler Y
    Rev Med Suisse Romande; 2004 Jan; 124(1):31. PubMed ID: 15095606
    [No Abstract]   [Full Text] [Related]  

  • 2. The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia.
    Juckel G; Morosini PL
    Curr Opin Psychiatry; 2008 Nov; 21(6):630-9. PubMed ID: 18852573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tools for measuring clinical effectiveness.
    Naber D; Vita A
    Eur Neuropsychopharmacol; 2004 Nov; 14 Suppl 4():S435-44. PubMed ID: 15572262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The therapeutic problem of schizophrenia; new clinical & statistical contributions on Fiamberti's acetylcholine method in the treatment of dissociative syndromes].
    FABBRI W; SALVATORES U
    Rass Studi Psichiatr; 1958; 47(2):119-88. PubMed ID: 13579288
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic approach in dysfunctions of schizophrenia based on the disability theory].
    Hachiya H
    Seishin Shinkeigaku Zasshi; 1985; 87(10):717-25. PubMed ID: 3837888
    [No Abstract]   [Full Text] [Related]  

  • 6. Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention.
    Moritz S; Woodward TS
    Curr Opin Psychiatry; 2007 Nov; 20(6):619-25. PubMed ID: 17921766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Family interventions in schizophrenia. From theory to the real world in Portugal today].
    Gonçalves-Pereira M; Xavier M; Neves A; Barahona-Correa B; Fadden G
    Acta Med Port; 2006; 19(1):1-8. PubMed ID: 16987438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Schizophrenia today].
    Delion P
    Soins Psychiatr; 1981 Dec; (14):2. PubMed ID: 6917416
    [No Abstract]   [Full Text] [Related]  

  • 9. First-episode schizophrenia. A window of opportunity for optimizing care and outcomes.
    Buckley PE; Evans D
    Postgrad Med; 2006 Sep; Spec No():5-19. PubMed ID: 17128657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic and neurophysiologic aspects of transcranial magnetic stimulation in schizophrenia.
    Saba G; Schurhoff F; Leboyer M
    Neurophysiol Clin; 2006; 36(3):185-94. PubMed ID: 17046611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in therapeutic stance in family therapy--what has been brought by narrative approach].
    Narabayashi R
    Seishin Shinkeigaku Zasshi; 2006; 108(2):142-8. PubMed ID: 16755715
    [No Abstract]   [Full Text] [Related]  

  • 12. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia.
    Shoval G; Weizman A
    Eur Neuropsychopharmacol; 2005 May; 15(3):319-29. PubMed ID: 15820422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New strategies in schizophrenia: impact of endophentotypes].
    Opgen-Rhein C; Neuhaus A; Urbanek C; Dettling M
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S194-9. PubMed ID: 15586310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ego-pathology, body experience, and body psychotherapy in chronic schizophrenia.
    Röhricht F; Papadopoulos N; Suzuki I; Priebe S
    Psychol Psychother; 2009 Mar; 82(Pt 1):19-30. PubMed ID: 18789189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A collaborative approach to targeted treatment development for schizophrenia: a qualitative evaluation of the NIMH-MATRICS project.
    Bromley E
    Schizophr Bull; 2005 Oct; 31(4):954-61. PubMed ID: 16166607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neural basis of relational memory deficits in schizophrenia.
    Ongür D; Cullen TJ; Wolf DH; Rohan M; Barreira P; Zalesak M; Heckers S
    Arch Gen Psychiatry; 2006 Apr; 63(4):356-65. PubMed ID: 16585464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic implications of a selective alpha7 nicotinic receptor abnormality in schizophrenia.
    Deutsch SI; Rosse RB; Schwartz BL; Weizman A; Chilton M; Arnold DS; Mastropaolo J
    Isr J Psychiatry Relat Sci; 2005; 42(1):33-44. PubMed ID: 16134405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Various data on the efficiency of new drugs in schizophrenia].
    COULLAUT MENDIGUTIA R
    Medicina (Madr); 1957 Nov; 25(11):429-50. PubMed ID: 13515933
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroimaging-genetic paradigms: a new approach to investigate the pathophysiology and treatment of cognitive deficits in schizophrenia.
    Roffman JL; Weiss AP; Goff DC; Rauch SL; Weinberger DR
    Harv Rev Psychiatry; 2006; 14(2):78-91. PubMed ID: 16603474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic process and management of schizophrenia in Spain: the ACEE project].
    Baca Baldomero E; Leal Cercós C; Varela C; Riesgo Y; Roca M
    Actas Esp Psiquiatr; 2006; 34(4):224-30. PubMed ID: 16823682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.